News in the Life Sciences Industry

- FN Media Group Presents Microsmallcap.com Market Commentary

NEW YORK, May 29, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, Chief Executive Officer of Relmada, will present a corporate... Read more ››

NEW YORK, May 29, 2020 /PRNewswire/ -- Several recent developments indicate that psychedelic products for medical use are getting the attention of businesses and politicians alike. For example, earlier in April, a New York lawmaker Read more ››

PLAINVIEW, N.Y., May 29, 2020 /PRNewswire/ -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, announces the launch of COVID-19 testing utilizing the FDA EUA approved ThermoFisher TaqPath RT-PCR COVID-19 Combo kit.

LONG BEACH, Calif., May 29, 2020 /PRNewswire/ -- Investigators at MedStar Washington Hospital Center and Nagourney Cancer Institute report the results of a study that examined the impact of prior FOLFOX chemotherapy exposure on Oxaliplatin resistance as a potentially important contributing factor... Read more ››

SAN FRANCISCO, May 29, 2020 /PRNewswire/ -- Arterys, a leading global medical imaging platform to deliver clinical AI products over the internet, just received its seventh USA FDA clearance and announced its latest round of funding -- a $28 million Series C investment from a syndicate led by... Read more ››

- 3D systems manufacturers keen on meeting range of demands for medical devices for healthcare industry; investment in services and software to support revenue growth

TORREY PINES, Calif., May 29, 2020 /PRNewswire/ -- EpicentRx, a next-generation clinical immuno-oncology company, today announced the appointment of physician, scientist and businessman Tony Reid, M.D., Ph.D., as the company's chief executive officer. Dr. Reid who is a co-founder and formerly... Read more ››

CHICAGO, May 29, 2020 /PRNewswire/ -- According to the new market research report "Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Check Point Inhibitors, Interferons, and Interleukins), Therapy Area (Cancer, Autoimmune diseases& Inflammatory, Infectious Diseases), End User... Read more ››

SECAUCUS, N.J., May 29, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference. Mark Guinan, Executive Vice President and CFO and... Read more ››

RYE, N.H., May 29, 2020 /PRNewswire/ -- In 2020 with the COVID-19 pandemic, the annual Less Cancer bike ride has gone virtual on June 6 and 7 with riders selecting their preferred ride length--15, 33 or 64 miles. Called the "Alone but Together Bike Ride," riders are riding solo in their hometowns... Read more ››

DUBLIN, May 29, 2020 /PRNewswire/ -- The Read more ››

DUBLIN, May 29, 2020 /PRNewswire/ -- The Read more ››

BRIDGEWATER, N.J., May 29, 2020 /PRNewswire/ -- Menlo Therapeutics Inc. (Nasdaq: MNLO) ("Menlo" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that the U.S. Food and Drug... Read more ››

SILVER SPRING, Md., May 29, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today granted approval to Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate) capsules, co-packaged for oral use, for the management of heavy... Read more ››